DIStress-AG: Association Between a Peri-traumatic Dissociation State and the Occurrence of Post-traumatic Stress Syndrome

Sponsor
University Hospital, Brest (Other)
Overall Status
Completed
CT.gov ID
NCT03930966
Collaborator
(none)
148
1
1
32.2
4.6

Study Details

Study Description

Brief Summary

Patients will be selected after studying clinical records.Patients who had general anesthesia due to an injury related to severe trauma within 6 to 12 months prior to inclusion will be included.

Three self-survey will be completed by the patient: PDEQ, PCL-5 and a demographic questionnaire. According to the PDEQ and PCL-5 scores, an association between a peri-traumatic dissociation state and a post-traumatic stress disorder can be established.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: PDEQ, PCL-5 and demographic survey
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
148 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
Prospective StudyProspective Study
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Study of the Association Between a Peri-traumatic Dissociation State and the Occurrence of Post-traumatic Stress Syndrome After Severe Trauma Requiring General Anesthesia
Actual Study Start Date :
Apr 9, 2019
Actual Primary Completion Date :
Dec 15, 2021
Actual Study Completion Date :
Dec 15, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: PDEQ, PCL-5 and demographic survey

State of the patient evaluated with questionnaires to make the connection between peri-traumatic dissociation and the occurrence of post-traumatic stress disorder

Diagnostic Test: PDEQ, PCL-5 and demographic survey
Questionnaires

Outcome Measures

Primary Outcome Measures

  1. Studying association between the presence of peri-traumatic dissociation state and the achievement of post-traumatic stress disorder between 6 and 12 months in traumatized patients [study baseline (6 to 12 months after initial hospitalisation)]

    Association will be measured using PDEQ scale and PCL-5 scale. The peri-traumatic dissociation will be evaluated by the Peri-traumatique Dissociation Experience Questionnary (PDEQ scale). This questionnaire contains ten items to study the presence or not of a peri-traumatic dissociation state. The items are scored on a 5-point Likert scale ranging from 1 (not at all true) to 5 (extremely true). The total score is the sum of all the items. A score from 15 indicates a significant dissociation. The presence or not of a Post-Traumatic Stress Disorder (PTSD) will be evaluated by the Post-Traumatic Stress Disorder Checklist Scale-Version DSM 5 (PCL-5). This questionnaire contains twenty items to study the presence or not of a PTSD. A total score for symptom severity (0-80) can be obtained by summing the scores for each of the 20 items. A score over 31 indicates a PTSD.

Secondary Outcome Measures

  1. Measurement of the frequency of PTSD after severe trauma requiring general anesthesia. [study baseline (6 to 12 months after initial hospitalisation)]

  2. Research of Risk Factors Associated with the Occurrence of PTSD [study baseline (6 to 12 months after initial hospitalisation)]

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients with general anesthesia for a surgical wound with violent trauma in the road, a fall of more than 6 meters, burn, accident at work, explosion, aggression) in the 6 to 12 months before the inclusion

  • Time between trauma and general anesthesia should not exceed 48 hours

  • Patient agreeing to participate in the study.

Exclusion Criteria:
  • Minor patients

  • Patients under curatorship, and tutorship

  • Patient deprived of liberty

  • Patients who do not speak French

  • Patients who are not in satisfactory neurological state to answer the questionnaire (pyschotic, demented states)

  • Patients who have been sedated (apart from general anesthesia) when receiving or having a Glasgow score <14

Contacts and Locations

Locations

Site City State Country Postal Code
1 CHRU Brest Brest France 29200

Sponsors and Collaborators

  • University Hospital, Brest

Investigators

  • Principal Investigator: Philippe ARIES, Dr, philippe.aries@chu-brest.fr

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Brest
ClinicalTrials.gov Identifier:
NCT03930966
Other Study ID Numbers:
  • DIStress-AG (29BRC18.0200)
First Posted:
Apr 29, 2019
Last Update Posted:
Jan 5, 2022
Last Verified:
Sep 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University Hospital, Brest
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 5, 2022